Incremental peritoneal dialysis with one exchange
Part of Kidney & urinary clinical trials.
This trial tests a way of doing peritoneal dialysis (a type of home dialysis for kidney failure) that uses a special fluid called icodextrin once a day. It aims to see if this approach is safe and works well for people who are just starting dialysis and still pass urine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have stage 5 chronic kidney disease (advanced kidney failure) and be planning to start peritoneal dialysis.
- Your kidney function (eGFR) should be at least 5 ml/min, and you should produce at least 800 ml of urine per day (about 3 cups).
- You must not have had a severe allergic reaction to icodextrin or glucose-based dialysis fluids.
- You must not have a serious ongoing illness like cancer, hepatitis, or severe heart disease, or an active severe infection.
- You must not be pregnant, planning to become pregnant, or breastfeeding, and you cannot be in another clinical study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special dialysis fluid called icodextrin can help people on a low-dose form of peritoneal dialysis stay on that low dose longer before needing a full dose. It is for adults who still make some urine and can do dialysis at home.
This study tests whether using two evening dialysis fluid bags (with a special fluid called icodextrin) can help control blood pressure better than the usual one bag. This might be helpful for children who have high blood pressure and low urine output while on peritoneal dialysis.
This trial tests a gradual approach to starting peritoneal dialysis (a type of dialysis done at home) for people who are new to dialysis. It aims to see if slowly increasing the dose is safe and helpful.
This Phase 3 trial studies how well a new peritoneal dialysis solution works and whether it is safe. It’s meant for adults with kidney failure who already do a specific type of at-home dialysis.
This study tests whether continuous glucose monitors (CGMs) work accurately in people doing peritoneal dialysis with icodextrin solution. It may help you manage your diabetes better by showing your glucose levels in real time.
This study tests a simpler way to check how well your peritoneal dialysis is working, using a single exchange instead of collecting all the fluid. If successful, it could make monitoring your treatment easier and more convenient.
Hear when a new Peritoneal Dialysis Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.